Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
129,929,313
-
Total 13F shares
-
36,308,797
-
Share change
-
+1,705,764
-
Total reported value
-
$716,870,214
-
Price per share
-
$19.75
-
Number of holders
-
71
-
Value change
-
+$25,393,622
-
Number of buys
-
45
-
Number of sells
-
30
Institutional Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q1 2021
As of 31 Mar 2021,
Vaxcyte, Inc. - COMMON STOCK (PCVX) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,308,797 shares.
The largest 10 holders included
TPG Group Holdings (SBS) Advisors, Inc., JANUS HENDERSON GROUP PLC, Abingworth LLP, RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, FRAZIER MANAGEMENT LLC, BlackRock Inc., Medicxi Ventures Management (Jersey) Ltd, STATE STREET CORP, and Pivotal bioVenture Partners Investment Advisor LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.